; the control group included those diagnosed with non-cardiac chest pain. Mean serum levels of D-dimer, creatine kinase-MB (CK-MB) and troponin I (TPI) were compared between the groups. Levels of D-dimer, CK-MB and TPI in the patient group were significantly higher than in the control group. There were also significantly higher D-dimer, CK-MB and TPI levels in the STEMI and NSTEMI patient subgroups compared with the control group. Only the D-dimer level was significantly higher in the USAP subgroup versus the control group. The sensitivity and specificity of D-dimer for ACS were 83.7% and 95.4%, respectively, suggesting that evaluating D-dimer levels might be useful in the emergency room for diagnosing ACS and predicting mortality in patients presenting with acute chest pain.
Introduction
Chest pain is a very common reason for presentation to the emergency department, and the early diagnosis and prognostic evaluation of acute chest pain must be carried out in this department: chest pain might be the first and only symptom of acute coronary syndrome (ACS). The diagnosis of ischaemic chest pain in the emergency department is currently based on clinical history, serum enzyme levels and electrocardiogram (ECG) findings. 1 Serial ECG and serum enzyme measurements are very useful for the recognition of myocardial infarction (MI) and unstable angina pectoris (USAP), but have limited diagnostic value in the early stages of these syndromes. Cardiac enzyme levels may take several hours to rise after pain onset and the ECG has suboptimal sensitivity for the early diagnosis of MI. 2 -4 Acute coronary syndrome occurs when an unstable plaque ruptures and activates M Orak, M Üstündag, C Güloglu et al. D-dimer levels in early diagnosis of acute coronary syndrome coagulation at the site, blocking blood flow and causing ischaemic injury to the heart. Thrombogenesis is the final process whereby exposed tissue factor triggers the activation of coagulation and the freshly formed clot fills the coronary artery lumen. Several biochemical markers of thrombus formation -including fibrinogen, prothrombin fragment, thrombin-antithrombin complex and fibropeptide A -have been associated with an increased risk of MI. 5 D-dimer is the primary degradation product of cross-linked fibrin and, therefore, serves as a direct marker of ongoing coagulation with fibrinolysis. 6 D-dimer levels have also been shown to correlate well with subsequent coronary artery events. 7 The aim of the present study was to investigate the diagnostic potential of the serum D-dimer level for ACS in patients admitted to the emergency department complaining of chest pain. A standard study form and an acknowledged patient approval form were completed in the resuscitation room for all patients with sudden-onset chest pain, who were being diagnosed and treated for this condition for the first time. Routine blood samples, blood samples required for D-dimer measurements and an ECG were taken upon their written approval to accept treatment and participate in the study. Demographic data, ECG interpretations, cardiac enzyme results and D-dimer levels of the patients at the time of admittance were recorded on standard work forms.
Patients and methods

PATIENT POPULATION AND STUDY DESIGN
Those presenting with chest pain and diagnosed as having ACS were identified as the patient group; those diagnosed with noncardiac chest pain were identified as the control group. All patients were evaluated by a single cardiology specialist and patients who were considered to be non-ischaemic in the control group were given an exercise stress test. Patients in whom the test results were negative were included in the control group.
Acute coronary syndrome encompasses USAP, non-ST elevated MI (NSTEMI) and ST elevated MI (STEMI). 8 Patients with typical resting chest pain lasting > 20 min, in whom chest pain had started as a new symptom within the previous 2 months and in whom the intensity of the pain had increased, together with no increase in myocardial enzymes, were defined as the USAP subgroup. Those patients with typical chest pain lasting > 30 min, in whom cardiac enzyme increases accompanied ST segment M Orak, M Üstündag, C Güloglu et al. D-dimer levels in early diagnosis of acute coronary syndrome depression and T-wave negativity, were included in the NSTEMI subgroup. Patients who had ST segment increases in two more neighbouring derivations on the ECG (2 mm in heart derivations and 1 mm in extremity derivations), together with increases in myocardial enzymes and troponin I (TPI), were included in the STEMI subgroup.
BIOCHEMICAL MEASUREMENTS
Blood samples taken from all subjects in the patient and control groups were used for routine biochemical tests, complete blood counts and measurement of the serum levels of the following cardiac markers: (i) creatine kinase-MB (CK-MB), measured using a chemiluminescent method (reference interval 0 -24 U/l; Architect C 8000; Abbott Laboratories, Abbott Park, IL, USA); (ii) TPI, measured using a chemiluminescent method (reference interval 0.00 -1.00 ng/ml; Architect C 8000); and (iii) D-dimer (reference interval 0 -0.5 µg/ml; ACL 200; Diamond Diagnostics Inc., Holliston, MA, USA). Researchers measured the plasma CK-MB, TPI and D-dimer levels in a blinded manner.
STATISTICAL ANALYSES
Results are presented as mean ± SD. Univariate statistical analyses were made by using the χ 2 -test for categorical variables and the t-test for continuous variables. For within-group comparisons, single-direction Kruskal-Wallis variance analysis and the Mann-Whitney U-test as a multiple comparison method were used. The cut-off levels used for D-dimer, CK-MB and TPI were 0.5 µg/ml, 24 U/l and 1.00 ng/ml, respectively. The sensitivity and specificity of these cardiac markers for diagnosing ACS were calculated. For between-group comparisons a P-value < 0.01 was considered to be statistically significant; for all other comparisons a P-value < 0.05 was considered to be statistically significant.
Results
PATIENTS
This study was carried out on 241 patients admitted to the emergency department because of sudden-onset chest pain. Of these, 63.5% (n = 153) formed the patient group and 36.5% (n = 88) formed the control group. In the overall study population, 59.3% (n = 143) were male and 40.7% (n = 98) were female. The mean ± SD age was 61.82 ± 11.2 years (range 34 -90 years) and the mean ± SD admission time was 4.66 ± 2.07 h (range 1 -12 h). Of the control group, 67.0% (n = 59) were male and 33.0% (n = 29) were female, with a mean ± SD age of 60.40 ± 9.48 years. Of the patient group, 54.9% (n = 84) were male and 45.1% (n = 69) were female, with a mean ± SD age of 62.60 ± 12.04 years. No significant differences were identified between the control and patient groups in terms of mean age and sex distribution. When the patient group was classified according to the ACS subtypes, 28.1% (n = 43) were included in the USAP subgroup, 35.3% (n = 54) in the NSTEMI subgroup and 36.6% (n = 56) in the STEMI subgroup.
D-DIMER AND CARDIAC MARKERS
Levels of CK-MB, TPI and D-dimer for both groups are shown in Table 1 . When the control group and patients grouped according to their ACS sub-type were compared, there was a statistically significant difference in the levels of CK-MB (P < 0.001), TPI (P < 0.001) and D-dimer (P < 0.001) between the STEMI and NSTEMI subgroups and the control group (Table 2) . There was a statistically significant difference between the USAP subgroup and the control group for Ddimer levels only (P < 0.001). When the STEMI and NSTEMI subgroups were M Orak, M Üstündag, C Güloglu et al. D-dimer levels in early diagnosis of acute coronary syndrome compared, there were no significant differences in the levels of CK-MB, TPI and Ddimer. In terms of identifying patients with ACS: D-dimer sensitivity was 83.7% and specificity was 95.4%; CK-MB sensitivity was 74.5% and specificity was 62.5%; and TPI sensitivity was 69.2% and specificity was 98.9% ( Table 3 ). The distribution of the control and patient groups according to Ddimer values is shown in Fig. 1 .
MORTALITY AND D-DIMER LEVELS
Ten patients (6.5%) from the ACS patient group died; seven were male and three were female. Six of the deceased patients had STEMI and four had NSTEMI. A significant difference was observed between mean serum D-dimer concentrations in living and deceased patients (2.01 ± 1.91 and 6.51 ± 3.80 µg/ml, respectively; P = 0.005). No significant difference was observed between mean serum CK-MB and TPI concentrations in living and deceased patients.
Discussion
Five million people annually are admitted to emergency departments with chest pain in the USA. 9 Triage of these patients is important and often difficult for emergency physicians. 10 In some patients with coexisting cardiac pathology, such as left ventricular hypertrophy or previous MI, the initial ECG is indeterminate and cannot be used to make a diagnosis. 11 -13 In several studies, 5% of patients who were discharged from the emergency department because of normal ECG were later diagnosed as having ACS. 14, 15 There is, therefore, a need for reliable cardiac markers that could be used to identify these undiagnosed ACS patients before they are prematurely discharged from the emergency department. In this respect, D-dimer is considered to be one of the more useful markers due to the role it plays in ACS pathophysiology. TPI and CK-MB are routinely used in the diagnosis of ACS, but their levels are not elevated during the first few hours following symptom onset and their usefulness in the early diagnosis of chest pain is disputable. D-dimer levels rise earlier than cardiac injury markers (including myoglobin) in acute ischaemic events because D-dimer is involved at an earlier stage in the pathophysiological process of MI and USAP. 1 D-dimer is an enzymatic degradation product that forms as a result of plasmin lysis of cross-linked fibrin clots. The plasma level of D-dimer is important for assessing the patient's fibrinolytic status. 16 In studies by Bounameaux et al., 17, 18 D-dimer testing was established as a useful aid in the M Orak, M Üstündag, C Güloglu et al. D-dimer levels in early diagnosis of acute coronary syndrome diagnosis of deep vein thrombosis of the lower limbs and pulmonary embolism. The relationship between serum D-dimer levels and ACS is unclear and published data are contradictory. For example, small studies show that D-dimer levels are higher in patients with MI than in patients with other forms of ACS. 19 -21 In contrast, Gurfinkel et al. 22 found normal D-dimer concentrations in patients with MI compared with healthy volunteers. In a study of 300 patients admitted to the emergency department with acute chest pain, Bayes-Genis et al. 1 showed that D-dimer levels in acute MI and USAP were considerably elevated secondary to MI. Similarly, in the present study, serum Ddimer levels were significantly higher in patients admitted to the emergency department with chest pain with a diagnosis of ACS, compared with levels in those admitted with non-cardiac chest pain.
Creatine kinase-MB, myoglobulin and TPI are generally used as markers of ACS, but these markers directly reflect the damage to myocardial muscle and do not reflect coronary thrombosis. Markers that reflect the obstructive events in the coronary arteries would be more useful than those reflecting the damage to myocardial muscles. 23 Elevated D-dimer concentrations may reflect a systemic prothrombotic state and, possibly, focal vessel-wall related fibrin formation and degradation associated with unstable atherosclerotic plaque activity. 24 Ieko et al. 23 showed that D-dimer and plasmin-plasmin inhibitor complex levels in the acute phase of ACS were significantly higher than those in the recovery phase, suggesting intracoronary thrombosis. Specifically, D-dimer concentrations were increased in the peripheral blood of patients with USAP, without overlap with levels in patients with stable angina. 19 Shitrit et al. 7 demonstrated that serum D-dimer levels a Sensitivity was calculated as the percentage of patients with confirmed acute coronary syndrome whose results were at or above the cut-off level. b Specificity was calculated as the percentage of patients in the control group whose results were below the cut-off level. The cut-off levels for D-dimer, creatine kinase-MB and troponin I were 0.5 µg/ml, 24 U/l and 1.0 ng/ml, respectively. there were no significant differences in the CK-MB and TPI levels. Like Bayes-Genis et al., 1 we suggest that the D-dimer level is useful for diagnosing USAP in patients admitted to the emergency department with acute chest pain. For this reason, Bayes-Genis et al. 1 suggested that serum D-dimer levels should be studied, in addition to other cardiac markers, in patients presenting to the emergency department with acute chest pain and normal ECG findings.
Lee et al. 21 showed that marked increases in circulating D-dimer were indicative of thrombotic complications in patients with MI, suggesting that D-dimer, besides being a useful marker for early diagnosis, is also a risk factor for the development of MI complications. Oldgren et al. 25 found that at long-term follow-up (median 29 months) in patients with USAP, higher baseline levels of D-dimer correlated with increased mortality. Of the six patients in the present study who died, two had STEMI, four had NSTEMI and none had USAP. Serum D-dimer levels were significantly higher in patients who died compared with those who lived, and there were no significant differences in CK-MB and TPI levels between survivors and nonsurvivors. These findings suggest that D-dimer levels are more valuable than CK-MB and TPI levels in predicting mortality, although it should be acknowledged that the patient numbers in the present study were very low.
There were a number of limitations to the present study. First, the study was based in a single emergency department. Secondly, it was only possible to provide data for one time-point for each patient. Finally, the study was undertaken in a small patient population. Thus, the association between Ddimer levels and myocardial damage should be studied using serial D-dimer measurements in a larger patient population.
In conclusion, serum D-dimer levels appear to be useful for diagnosing ACS and might assist in the prediction of mortality, in patients presenting at the emergency department with acute chest pain.
